Clinical Trial Update: Combination Chemotherapy With or Without Cyclophosphamide and Prednisone in Treating Older Patients With Multiple Myeloma [Phase 3]

View source ↗

Summary

An update on a Phase 3 trial evaluating combination chemotherapy with or without cyclophosphamide and prednisone in older patients with multiple myeloma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma
• Plasma Cell Neoplasm

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• PREDNISONE (Prednisone)

Snippet

Sponsor: Medical Research Council | Conditions: Multiple Myeloma and Plasma Cell Neoplasm | Phase 3 | Status: UNKNOWN